Correction: miRNA101a secreted by EATMs regulates atrial fibrillation through the PDGF-mediated PI3K/AKT pathway

In this study, we observed (Figure 1A) a significant reduction in the expression of miRNA101a in the LAA epicardial adipose tissue and peripheral blood of patients with AF compared to the control group. This was determined by RT-PCR analysis of clinical tissue samples from the LAA, showing that miRNA101a levels were higher in the AF group than in the SR group, with the difference being statistically significant. These results are consistent with our experimental expectations. Similarly, we found the same results in animal experiments (Figure 1B): miRNA101a levels were significantly reduced in the LAA epicardial adipose tissues of rats subjected to esophageal pacing to create an AF model, compared to the control group. Additionally, we collected LAA tissues from different patient groups for HE and Masson staining. The HE staining results (Figure 1C) revealed pronounced inflammatory cell infiltration and disorganized cellular structures in the AF group compared to the SR group. Masson staining results (Figure 1D)indicated increased collagen deposition and significantly enhanced fibrosis in the myocardial tissues of the AF group. These findings suggest that myocardial fibrosis is the primary pathological mechanism underlying AF.[Due to a handwriting error]. A correction has been made to the section [Result 3.1 miRNA101a involve of in the process of AF myocardial fibrosis]:"[In this study, we observed (Figure 1A) a significant reduction in the expression of miRNA101a in the LA A epicardial adipose tissue and peripheral blood of patients with AF compared to the control group. This was determined by RT-PCR analysis of clinical tissue samples from the LAA, showing that miRNA101a lev els were lower in the AF group than in the SR group, with the difference being statistically significant. Th ese results are consistent with our experimental expectations. Similarly, we found the same results in an imal experiments (Figure 1B): miRNA101a levels were significantly reduced in the LAA epicardial adipose tissues of rats subjected to esophageal pacing to create an AF model, compared to the control group. A dditionally, we collected LAA tissues from different patient groups for HE and Masson staining. The HE st aining results (Figure 1C) revealed pronounced inflammatory cell infiltration and disorganized cellular str uctures in the AF group compared to the SR group. Masson staining results (Figure 1D) indicated increas ed collagen deposition and significantly enhanced fibrosis in the myocardial tissues of the AF group. The se findings suggest that myocardial fibrosis is the primary pathological mechanism underlying AF.]" The original version of this article has been updated.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-05-11
DOI
https://doi.org/10.3389/fphar.2026.1861200
Primary Topic
Cardiovascular Disease and Adiposity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: miRNA101a secreted by EATMs regulates atrial fibrillation through the PDGF-mediated PI3K/AKT pathway

Zheng Sihao, Zhang Zheng, D Jiang, Qin Xiaoli et al.
Frontiers in Pharmacology
Cardiovascular Disease and Adiposity
article

Correction: miRNA101a secreted by EATMs regulates atrial fibrillation through the PDGF-mediated PI3K/AKT pathway

Zheng Sihao, Zhang Zheng, D Jiang, Qin Xiaoli, Liang Weitao, Yue Honghua, Li Xiaoliang, Wu Zhong
article en

Abstract

In this study, we observed (Figure 1A) a significant reduction in the expression of miRNA101a in the LAA epicardial adipose tissue and peripheral blood of patients with AF compared to the control group. This was determined by RT-PCR analysis of clinical tissue samples from the LAA, showing that miRNA101a levels were higher in the AF group than in the SR group, with the difference being statistically significant. These results are consistent with our experimental expectations. Similarly, we found the same results in animal experiments (Figure 1B): miRNA101a levels were significantly reduced in the LAA epicardial adipose tissues of rats subjected to esophageal pacing to create an AF model, compared to the control group. Additionally, we collected LAA tissues from different patient groups for HE and Masson staining. The HE staining results (Figure 1C) revealed pronounced inflammatory cell infiltration and disorganized cellular structures in the AF group compared to the SR group. Masson staining results (Figure 1D)indicated increased collagen deposition and significantly enhanced fibrosis in the myocardial tissues of the AF group. These findings suggest that myocardial fibrosis is the primary pathological mechanism underlying AF.[Due to a handwriting error]. A correction has been made to the section [Result 3.1 miRNA101a involve of in the process of AF myocardial fibrosis]:"[In this study, we observed (Figure 1A) a significant reduction in the expression of miRNA101a in the LA A epicardial adipose tissue and peripheral blood of patients with AF compared to the control group. This was determined by RT-PCR analysis of clinical tissue samples from the LAA, showing that miRNA101a lev els were lower in the AF group than in the SR group, with the difference being statistically significant. Th ese results are consistent with our experimental expectations. Similarly, we found the same results in an imal experiments (Figure 1B): miRNA101a levels were significantly reduced in the LAA epicardial adipose tissues of rats subjected to esophageal pacing to create an AF model, compared to the control group. A dditionally, we collected LAA tissues from different patient groups for HE and Masson staining. The HE st aining results (Figure 1C) revealed pronounced inflammatory cell infiltration and disorganized cellular str uctures in the AF group compared to the SR group. Masson staining results (Figure 1D) indicated increas ed collagen deposition and significantly enhanced fibrosis in the myocardial tissues of the AF group. The se findings suggest that myocardial fibrosis is the primary pathological mechanism underlying AF.]" The original version of this article has been updated.

Frontiers in PharmacologyVol. 17
Sichuan University (CN), West China Hospital of Sichuan University (CN), Neijiang Normal University (CN)
Openalex Percentile: Top 8%
Cardiovascular Disease and Adiposity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.